Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2015 | 10-2014 | 07-2014 | 04-2014 | 01-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -462 | 50 | -1 | -2,385 | -2,656 |
| Depreciation Amortization | 203 | 116 | 368 | 281 | 192 |
| Other Working Capital | -350 | -569 | -596 | -251 | 45 |
| Other Operating Activity | -996 | -632 | -3,345 | -404 | 756 |
| Operating Cash Flow | $-1,605 | $-1,036 | $-3,574 | $-2,759 | $-1,664 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 884 | 884 | 884 |
| Purchase Sale Intangibles | -47 | -14 | -90 | -62 | -35 |
| Other Investing Activity | -47 | -14 | -90 | -62 | -35 |
| Investing Cash Flow | $-47 | $-14 | $794 | $822 | $849 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -607 | -607 | -607 |
| Common Stock Issued | 1 | 1 | 2,303 | 2,303 | 2,123 |
| Other Financing Activity | 0 | 0 | 2,655 | 2,770 | 750 |
| Financing Cash Flow | $1 | $1 | $4,351 | $4,466 | $2,266 |
| Exchange Rate Effect | -9 | -5 | -11 | -19 | -19 |
| Beginning Cash Position | 3,270 | 3,270 | 1,709 | 1,709 | 1,709 |
| End Cash Position | 1,610 | 2,215 | 3,270 | 4,219 | 3,141 |
| Net Cash Flow | $-1,660 | $-1,054 | $1,561 | $2,510 | $1,432 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,605 | -1,036 | -3,574 | -2,759 | -1,664 |
| Free Cash Flow | -1,605 | -1,036 | -3,574 | -2,759 | -1,664 |